Institutional Ownership
Enanta Pharmaceuticals Inc
CUSIP 29251M106COMENTAQ1 2026
Institutional Holders
128
13F filers
Shares Held
24.45M
Aggregate institutional
Institutional Value
$260.88M
Q1 2026
Net New Holders
+2
21 new · 19 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions21
Increased48
Decreased33
Sold out19
Institutional Holders
128 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Janus Henderson Group PLC | 3.78M | $47.72M | +54.4K | Added |
| 2 | Blackrock, Inc. | 3.10M | $39.20M | +27.5K | Added |
| 3 | Farallon Capital Management LLC | 2.87M | $36.27M | +2.87M | New |
| 4 | Deep Track Capital, LP | 1.96M | $24.72M | 0 | Held |
| 5 | Spruce Street Capital LP | 932.6K | $11.78M | +542.9K | Added |
| 6 | Millennium Management LLC | 882.1K | $11.14M | +211.7K | Added |
| 7 | Geode Capital Management, LLC | 725.1K | $9.16M | +79.3K | Added |
| 8 | Renaissance Technologies LLC | 665.3K | $8.40M | +23.1K | Added |
| 9 | State Street Corp | 562.1K | $7.10M | +38.4K | Added |
| 10 | Hillsdale Investment Management Inc. | 435.5K | $5.50M | +13.2K | Added |
118 more institutional holders on Premium
See every fund holding Enanta Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders